神经递质受体活性与阿尔茨海默氏病中的粉样β病理之间的相互作用
Yuhan Nong1, Jung Soo Kim1, Litian Jia1
1Department of Biomedical Engineering, Columbia University, New York, NY, USA.
Journal of Alzheimer's disease : JAD
|May 19, 2025
概括
阿尔茨海默病涉及粉样β (Aβ) 影响神经递质受体. 准这些受体可能为阿尔茨海默病 (AD) 提供新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病 (AD) 的特点是粉样ββ (Aβ) 的积累.
- Aβ生产涉及由BACE-1和γ-分泌酶处理的粉样β蛋白前体 (AβPP).
- 焦点正在转向可溶性Aβ寡合体作为关键的神经毒性物种.
研究的目的:
- 审查Aβ和关键神经递质受体之间的相互作用.
- 了解这些相互作用如何导致AD的神经功能障碍.
- 探索针对这些受体进行AD治疗的治疗潜力.
主要方法:
- 对Aβ与神经递质受体相互作用的研究的文献综述.
- 对受体激素和对抗剂对Aβ病理学影响的研究分析.
- 综合了关于神经递质系统在阿尔茨海默氏症发病过程中的作用的发现.
主要成果:
- 甲β显著影响上腺体,乙胆,多巴胺,5-HT,谷氨酸和GABA受体的功能.
- 这些相互作用破坏了突触传输,损害了认知和感知功能.
- 这些受体的调制可以影响Aβ病理.
结论:
- 由Aβ诱导的神经递质受体功能障碍是AD的一个关键机制.
- 准神经递质受体为AD提供了一个有希望的治疗途径.
- 对受体调节的进一步研究可能会导致有效的AD治疗.
相关概念视频
Alzheimer's Disease: Overview
399
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
399
Alzheimer's Disease: Treatment
137
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
137
Amyloid Fibrils
9.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.1K
Excitatory and Inhibitory Effects of Neurotransmitters
9.6K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
9.6K
Enzyme-linked Receptors
76.7K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
76.7K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.1K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.1K


